The current study support this concept of altered p53 signaling in T2DM muscle cells by demonstrating that two direct transcriptional targets of p53 (DRAM1 and TP53INP1)27,39 are dysregulated in T2DM cells. The gene discussed is TP53INP1; the disease is type 2 diabetes mellitus.